These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 28062212

  • 1. Inhibition of CD147 expression promotes chemosensitivity in HNSCC cells by deactivating MAPK/ERK signaling pathway.
    Ma C, Wang J, Fan L, Guo Y.
    Exp Mol Pathol; 2017 Feb; 102(1):59-64. PubMed ID: 28062212
    [Abstract] [Full Text] [Related]

  • 2. Overexpression of CD147 contributes to the chemoresistance of head and neck squamous cell carcinoma cells.
    Huang Z, Wang L, Wang Y, Zhuo Y, Li H, Chen J, Chen W.
    J Oral Pathol Med; 2013 Aug; 42(7):541-6. PubMed ID: 23413783
    [Abstract] [Full Text] [Related]

  • 3. Upregulation of CD147 promotes cell invasion, epithelial-to-mesenchymal transition and activates MAPK/ERK signaling pathway in colorectal cancer.
    Xu T, Zhou M, Peng L, Kong S, Miao R, Shi Y, Sheng H, Li L.
    Int J Clin Exp Pathol; 2014 Aug; 7(11):7432-41. PubMed ID: 25550778
    [Abstract] [Full Text] [Related]

  • 4. miR-22 regulates cell invasion, migration and proliferation in vitro through inhibiting CD147 expression in tongue squamous cell carcinoma.
    Qiu K, Huang Z, Huang Z, He Z, You S.
    Arch Oral Biol; 2016 Jun; 66():92-7. PubMed ID: 26943814
    [Abstract] [Full Text] [Related]

  • 5. CD147 promotes progression of head and neck squamous cell carcinoma via NF-kappa B signaling.
    Yu B, Zhang Y, Wu K, Wang L, Jiang Y, Chen W, Yan M.
    J Cell Mol Med; 2019 Feb; 23(2):954-966. PubMed ID: 30421493
    [Abstract] [Full Text] [Related]

  • 6. Identification of cisplatin-resistance related genes in head and neck squamous cell carcinoma.
    Yamano Y, Uzawa K, Saito K, Nakashima D, Kasamatsu A, Koike H, Kouzu Y, Shinozuka K, Nakatani K, Negoro K, Fujita S, Tanzawa H.
    Int J Cancer; 2010 Jan 15; 126(2):437-49. PubMed ID: 19569180
    [Abstract] [Full Text] [Related]

  • 7. In vitro and in vivo prostate cancer metastasis and chemoresistance can be modulated by expression of either CD44 or CD147.
    Hao J, Madigan MC, Khatri A, Power CA, Hung TT, Beretov J, Chang L, Xiao W, Cozzi PJ, Graham PH, Kearsley JH, Li Y.
    PLoS One; 2012 Jan 15; 7(8):e40716. PubMed ID: 22870202
    [Abstract] [Full Text] [Related]

  • 8. RAS/PI3K crosstalk and cetuximab resistance in head and neck squamous cell carcinoma.
    Rampias T, Giagini A, Siolos S, Matsuzaki H, Sasaki C, Scorilas A, Psyrri A.
    Clin Cancer Res; 2014 Jun 01; 20(11):2933-46. PubMed ID: 24696319
    [Abstract] [Full Text] [Related]

  • 9. Role of p38 MAPK in disease relapse and therapeutic resistance by maintenance of cancer stem cells in head and neck squamous cell carcinoma.
    Roy S, Roy S, Kar M, Padhi S, Saha A, Anuja K, Banerjee B.
    J Oral Pathol Med; 2018 May 01; 47(5):492-501. PubMed ID: 29575240
    [Abstract] [Full Text] [Related]

  • 10. p70S6K promotes IL-6-induced epithelial-mesenchymal transition and metastasis of head and neck squamous cell carcinoma.
    Wu D, Cheng J, Sun G, Wu S, Li M, Gao Z, Zhai S, Li P, Su D, Wang X.
    Oncotarget; 2016 Jun 14; 7(24):36539-36550. PubMed ID: 27174914
    [Abstract] [Full Text] [Related]

  • 11. CD147 promotes breast cancer migration and invasion by inducing epithelial-mesenchymal transition via the MAPK/ERK signaling pathway.
    Li F, Wang J, Yan YQ, Bai CZ, Guo JQ.
    BMC Cancer; 2023 Dec 08; 23(1):1214. PubMed ID: 38066486
    [Abstract] [Full Text] [Related]

  • 12. MEK Inhibition Overcomes Cisplatin Resistance Conferred by SOS/MAPK Pathway Activation in Squamous Cell Carcinoma.
    Kong LR, Chua KN, Sim WJ, Ng HC, Bi C, Ho J, Nga ME, Pang YH, Ong WR, Soo RA, Huynh H, Chng WJ, Thiery JP, Goh BC.
    Mol Cancer Ther; 2015 Jul 08; 14(7):1750-60. PubMed ID: 25939760
    [Abstract] [Full Text] [Related]

  • 13. Hypoxia-induced ROS promotes mitochondrial fission and cisplatin chemosensitivity via HIF-1α/Mff regulation in head and neck squamous cell carcinoma.
    Wu K, Mao YY, Chen Q, Zhang B, Zhang S, Wu HJ, Li Y.
    Cell Oncol (Dordr); 2021 Oct 08; 44(5):1167-1181. PubMed ID: 34460078
    [Abstract] [Full Text] [Related]

  • 14. Reversal of multidrug resistance by gefitinib via RAF1/ERK pathway in pancreatic cancer cell line.
    Xiao Z, Ding N, Xiao G, Wang S, Wu Y, Tang L.
    Anat Rec (Hoboken); 2012 Dec 08; 295(12):2122-8. PubMed ID: 22907845
    [Abstract] [Full Text] [Related]

  • 15. CD147 promotes invasion and MMP-9 expression through MEK signaling and predicts poor prognosis in hypopharyngeal squamous cell carcinoma.
    Suzuki S, Toyoma S, Kawasaki Y, Nanjo H, Yamada T.
    Adv Clin Exp Med; 2021 Jan 08; 30(1):41-48. PubMed ID: 33529506
    [Abstract] [Full Text] [Related]

  • 16. Proteome analysis of multidrug resistance of human oral squamous carcinoma cells using CD147 silencing.
    Kuang YH, Chen X, Su J, Wu LS, Li J, Chang J, Qiu Y, Chen ZS, Kanekura T.
    J Proteome Res; 2008 Nov 08; 7(11):4784-91. PubMed ID: 18816083
    [Abstract] [Full Text] [Related]

  • 17. Minor role of pregnane-x-receptor for acquired multidrug resistance in head and neck squamous cell carcinoma in vitro.
    Rigalli JP, Reuter T, Herold-Mende C, Dyckhoff G, Haefeli WE, Weiss J, Theile D.
    Cancer Chemother Pharmacol; 2013 May 08; 71(5):1335-43. PubMed ID: 23479137
    [Abstract] [Full Text] [Related]

  • 18. miRNA-24-3p promotes cell proliferation and regulates chemosensitivity in head and neck squamous cell carcinoma by targeting CHD5.
    Sun X, Xiao D, Xu T, Yuan Y.
    Future Oncol; 2016 Dec 08; 12(23):2701-2712. PubMed ID: 27513190
    [Abstract] [Full Text] [Related]

  • 19. Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway.
    Nakanishi H, Taccioli C, Palatini J, Fernandez-Cymering C, Cui R, Kim T, Volinia S, Croce CM.
    Oncogene; 2014 Feb 06; 33(6):702-12. PubMed ID: 23416980
    [Abstract] [Full Text] [Related]

  • 20. A novel splice variant of LOXL2 promotes progression of human papillomavirus-negative head and neck squamous cell carcinoma.
    Liu C, Guo T, Sakai A, Ren S, Fukusumi T, Ando M, Sadat S, Saito Y, Califano JA.
    Cancer; 2020 Feb 15; 126(4):737-748. PubMed ID: 31721164
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.